These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6354567)

  • 21. Vancomycin revisited: a reappraisal of clinical use.
    Cunha BA
    Crit Care Clin; 2008 Apr; 24(2):393-420, x-xi. PubMed ID: 18361953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An alarming problem in the therapy of infective endocarditis: the development of antibiotic-resistant strains].
    Enia F; Bella R; Mineo R; Mizio G; Reina G
    Ital Heart J Suppl; 2005 Mar; 6(3):121-7. PubMed ID: 15875497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction to vancomycin.
    Griffith RS
    Rev Infect Dis; 1981; 3 suppl():S200-4. PubMed ID: 7043707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vancomycin for treatment of bacterial meningitis.
    Gump DW
    Rev Infect Dis; 1981; 3 suppl():S289-92. PubMed ID: 6896243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
    Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR;
    Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
    Stryjewski ME; Graham DR; Wilson SE; O'Riordan W; Young D; Lentnek A; Ross DP; Fowler VG; Hopkins A; Friedland HD; Barriere SL; Kitt MM; Corey GR;
    Clin Infect Dis; 2008 Jun; 46(11):1683-93. PubMed ID: 18444791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
    Campelli A; Mantero E; Fabbri A; Nahum M; Ferraris R; Di Noto C
    Minerva Med; 1984 Feb; 75(8):385-90. PubMed ID: 6709217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin revisited.
    Cook FV; Farrar WE
    Ann Intern Med; 1978 Jun; 88(6):813-8. PubMed ID: 352213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
    Beloborodova NV
    Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Optimal vancomycin serum level in Staphylococcus aureus infections?].
    Bingen E; Mariani-Kurkdjian P; Nebbad B
    Med Mal Infect; 2006 Sep; 36(9):439-42. PubMed ID: 17027219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin, metronidazole, and tetracyclines.
    Ellison MJ
    Clin Podiatr Med Surg; 1992 Apr; 9(2):425-42. PubMed ID: 1586910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Septicemia due to polyresistant Staphylococcus aureus (author's transl)].
    Bonnardot JP; Bonvoisin R; Bryskier A
    Sem Hop; 1980 Nov 18-25; 56(43-44):1850-2. PubMed ID: 6256890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin.
    Hermans PE; Wilhelm MP
    Mayo Clin Proc; 1987 Oct; 62(10):901-5. PubMed ID: 3657307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin update.
    Smith BR; LeFrock JL
    Am Fam Physician; 1987 May; 35(5):223-5. PubMed ID: 3577993
    [No Abstract]   [Full Text] [Related]  

  • 40. Vancomycin therapy of bacterial endocarditis.
    Hook EW; Johnson WD
    Am J Med; 1978 Sep; 65(3):411-5. PubMed ID: 152580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.